Clinical Report: Linkages Between Parathyroid Hormone Levels and Atrial Fibrillation
Overview
This study investigates the association between parathyroid hormone (PTH) levels and atrial fibrillation (AF) in a cohort of 3,201 patients. Elevated PTH was found to be significantly associated with prevalent AF.
Background
Atrial fibrillation is a common arrhythmia linked to increased risks of stroke and heart failure. Understanding the factors that contribute to AF is crucial for effective management and prevention strategies. Parathyroid hormone, known for its role in calcium metabolism, has been implicated in cardiovascular health.
Data Highlights
Parameter
Value
Patients with AF
389 (12.2%)
OR for PTH in primary model
3.96 (2.32–6.76), p < 0.001
OR for PTH in fully adjusted model
2.32 (1.24–4.35), p = 0.009
Key Findings
389 patients (12.2%) had atrial fibrillation (AF).
PTH was significantly associated with AF in the primary multivariable model (OR 3.96).
The association remained significant after adjusting for mineral metabolism and medication variables (OR 2.32).
Adjustment for markers of cardiac dysfunction did not alter the significance of the PTH-AF association.
Elevated PTH may represent an independent correlate of AF rather than a surrogate of cardiac dysfunction.
Clinical Implications
Further research is needed to explore the mechanisms underlying the association between elevated parathyroid hormone levels and atrial fibrillation.
Conclusion
Elevated parathyroid hormone levels are associated with atrial fibrillation in patients undergoing coronary angiography.
